![Pernilla Abrahamsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pernilla Abrahamsson
Chief Operating Officer at
LIPUM AB
Profile
Pernilla Abrahamsson is the founder of MD Biomedical AB. She is currently the Chief Operating Officer at Lipum AB. Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Pernilla Abrahamsson active positions
| Companies | Position | Start |
|---|---|---|
| LIPUM AB | Chief Operating Officer | 2018-12-31 |
Former positions of Pernilla Abrahamsson
| Companies | Position | End |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 2019-03-31 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Founder | - |
Training of Pernilla Abrahamsson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Health Services |
Lipum AB
 Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
- Stock Market
- Insiders
- Pernilla Abrahamsson
